Literature DB >> 16740030

Mucin profiles in signet-ring cell carcinoma.

Minh D Nguyen1, Brian Plasil, Ping Wen, Wendy L Frankel.   

Abstract

CONTEXT: Signet-ring cell carcinoma (SRCC) is a poorly differentiated mucin-producing adenocarcinoma that may arise from many different organs, but all SRCCs share identical morphology. It is not possible to differentiate sites of origin for metastatic SRCC based on morphology alone. Mucins are high-molecular-weight glycoproteins differentially expressed in glandular epithelia and in adenocarcinomas.
OBJECTIVE: To identify mucin profiles of primary and metastatic SRCCs using immunohistochemistry to determine whether mucin staining could help distinguish sites of origin.
DESIGN: Forty-seven SRCCs, including 38 primary (21 stomach, 11 colorectum, and 6 breast) and 9 metastases from these primary sites were retrieved from archival files. Consecutive tissue sections were immunostained with monoclonal antibodies against MUC1, MUC2, MUC4, MUC5AC (MUC5), and MUC6 on separate slides. Cytoplasmic staining was scored based on proportion of positive tumor cells as follows: 0+ (<5%), 1+ (5%-25%), 2+ (26%-50%), and 3+ (>50%). Mucin profiles were recorded as MUC+, MUCv, and MUC- for consistent, variable, and negative expression, respectively.
RESULTS: The mucin profiles for gastric, colorectum, and breast SRCCs are MUC1.2.4.5.6v, MUC2.4+/MUC5v/ MUC1.6-, and MUC1+/MUC2.5.6v/MUC4-, respectively. Mucin profiles of metastatic cases shared profiles with their respective primaries.
CONCLUSIONS: Signet-ring cell carcinomas of the stomach, colorectum, and breast have distinct mucin expression patterns that are maintained in metastases. Mucin profiling may be useful to identify the origin of a metastatic SRCC of unknown primary.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740030     DOI: 10.5858/2006-130-799-MPISCC

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  12 in total

Review 1.  Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.

Authors:  Partha Mukhopadhyay; Subhankar Chakraborty; Moorthy P Ponnusamy; Imayavaramban Lakshmanan; Maneesh Jain; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2011-01-26

2.  Comparison between colorectal low- and high-grade mucinous adenocarcinoma with MUC1 and MUC5AC.

Authors:  Masayuki Onodera; Takashi Nishigami; Ikuko Torii; Ayuko Sato; Li-Hua Tao; Tatsuki R Kataoka; Reigetsu Yoshikawa; Tohru Tsujimura
Journal:  World J Gastrointest Oncol       Date:  2009-10-15

3.  An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

4.  HNF4A immunohistochemistry facilitates distinction between primary and metastatic breast and gastric carcinoma.

Authors:  R S van der Post; P Bult; I P Vogelaar; M J L Ligtenberg; N Hoogerbrugge; J H van Krieken
Journal:  Virchows Arch       Date:  2014-04-08       Impact factor: 4.064

5.  Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential.

Authors:  Hiroki Murakami; Hayao Nakanishi; Harunari Tanaka; Seiji Ito; Kazunari Misawa; Yuuichi Ito; Yuzuru Ikehara; Eisaku Kondo; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2012-03-27       Impact factor: 7.370

Review 6.  Mitochondrial DNA alterations in the progression of gastric carcinomas: unexplored issues and future research needs.

Authors:  Luciana Rigoli; Rosario Alberto Caruso
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

7.  Primary Mucinous Cystadenocarcinoma of the Breast: Cytologic Finding and Expression of MUC5 Are Different from Mucinous Carcinoma.

Authors:  Sung Eun Kim; Ji Hye Park; Soonwon Hong; Ja Seung Koo; Joon Jeong; Woo-Hee Jung
Journal:  Korean J Pathol       Date:  2012-12-26

8.  An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins.

Authors:  D Judy Shon; Stacy A Malaker; Kayvon Pedram; Emily Yang; Venkatesh Krishnan; Oliver Dorigo; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-17       Impact factor: 11.205

9.  An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

10.  Prognostic significance of mucin expression profiles in breast carcinoma with signet ring cells: a clinicopathological study.

Authors:  Ryuji Ohashi; Ayako Hayama; Keiko Yanagihara; Koji Yamashita; Takashi Sakatani; Hiroyuki Takei; Zenya Naito
Journal:  Diagn Pathol       Date:  2016-11-15       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.